Benchmark Holdings - Interim Results investor presentation (May 2023)

Benchmark Holdings plc, the aquaculture biotechnology company, conducted an investor presentation following publication of their Q2 & Interim results for the period to 31st March 2023.
Trond Williksen, CEO, and Septima Maguire, CFO ran investors through highlights of the period, which included strong performance across the three business divisions - Genetics, Advanced Nutrition and Health. They provided a detailed financial review and updated viewers on plans maintain a dual listing on Euronext Growth Oslo and AIM for the foreseeable future. Management also answered a range of investors questions. The video has been divided into chapters as below.

Timestamps
0:00:00 Introduction
0:00:46 Q2 FY23 highlights
0:05:32 Operational Update in Genetics
0:13:57 Operational Update in Advanced Nutrition
0:17:20 Operational Update in Health
0:21:36 Financial Update
0:27:50 Outlook
0:37:33 Questions & Answers